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Summary: A simplified and rapid method is described for phenotyping of sulfamethazine acetylation. Two hours
after a test dose of sulfamethazine, free and total sulfamethazine are estimated in blood drawn either by capillary or
venipuncture. The present method offers sharp segregation between slow and rapid acetylators, requires micro blood
volumes drawn from finger- or ear pucture, and is more convenient for population genetics survey as well as for
clinical investigations.
Eine vereinfachte Mikromethode zur Bestimmung des Acetylator-Phänotyps
Zusammenfassung: Eine verfeinerte Schnellmethode zur Phänotypisierung der Sulfamethazin-Acetylierung wird be-
schrieben. Schon 2 Stunden nach Belastung mit Sulfamethazin läßt sich freies und acetyliertes Sulfamethazin in
geringem Volumen von Kapillar- oder Venenblut bestimmen. Die Differenzierung in Langsam- und Schnellacetylierer
ist befriedigend. Die Methode erscheint besonders geeignet für genetische Felduntersuchungen und Bestimmungen in
der Klinik.
Acetylation is one of the principle pathways for the
metabolism of foreign arylamines in most mammalian
species. The genetic polymorphism of isoniazid acetyla-
tion in man (rapid or slow acetylator) is one of the few
established pharmacogenetic phenomena (1—3). It has
been shown that the isoniazid acetylator phenotype is
congruent with the acetylator phenotype of several
structurally unrelated drugs, such as sulfamethazine
(4), sulfapyridine (6), and presumably with serotonin
(3) and dapsone (7). Recently Weber & Brenner (8) in-
troduced a simple method for determining the acetyla-
tor phenotype, using sulfamethazine (10 mg/kg body
weight) as substrate (4). Four and ä half hours after
its oral application, venous blood or urine was collected.
The amount of 0.1 ml was dropped on filter paper and
dried at room temperature. By addition of tricMpro-
acetic acid the free acetylated sulfamethazine could be
dissolved again. The solution was then divided into two
portions, one portion was treated further with 4 mol/1
HC1 and boiled for one hour, the other portion was
kept at room temperature. The boiling in acidic environ-
ment causes the deacetylation of acetylated sulfa-
methazine. The total and free sulfamethazine of both
portions were estimated by diazptization according to
Bratton-Marshatt (9). Consequently, the percentage
of acetylation could be calculated. For the purpose
of population genetic studies we tried to simplify and
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shorten the procedure, and to avoid the venipuncture
which is difficult to deal with in certain countries or
diseases, e. g. in psychiatric patients.
Material, Method and Results
The method of Weber & Brenner (8) was tested intensively in
our laboratory, and it was used to study whole families. The
percentage of acetylation obtained from blood specimens gave
very satisfactory, reproducible results with blood sampled on
different occasions. The acetylation rate of 0.40 could be used
to differentiate the rapid (more than 0.40) from the slow (less
than 0.40) acetylator types. However, the acetylation rates
obtained from urine specimens were widely overlapping, and
were therefore unreliable for phenotyping purposes.
Forty members of our institute, whose acetylator phenotypes
were determined by other isoniazid measuring methods (10, 11)
joined the multiple studies described below and served as
controls.
Finger puncture and ear puncture versus venipuncture
Venous blood was collected with an heparinized syringe.
The capillary blood obtained from finger and ear puncture
was collected with either an heparinized micro blood collecting
tube (0.2 ml)1) or an heparinized micro he ma to exit capillary
tube (0.05 ml)2) or a 0.1 ml micropipette3).
The blood samples for the experiments with changing para-
meters were collected in the above mentioned ways (i. e. veni,
finger or ear puncture).
*) Yankee Natelson Micro Blood Collecting Tubes.
2) CAPILETS micro Hematoerit Capillary Tubes.
3) Brand Mikro Pipetten, 100 .
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It became evident that no deviation of results between
the different methods of blood sampling was to be
noticed. The acetylation rates obtained from finger
or ear puncture were in the same range as those obtained
by venipuncture.
Storage and samples
First of all it was proved that the blood sample measured directly
or after elution from the filter paper did not show any difference
in the final results. Further, the heparinized and dried blood
samples (on filter paper) were stored at room temperature, in
the refrigerator (4 °C) or on dried ice (- 20 °C).
The sterile heparinized blood samples and the dried blood
samples maintained their original acetylation percentage
after as long as 21 days of storage, even at room tempera-
ture. This means that refrigeration is unnecessary during
storage, which is especially convenient for transportation
between countries. Moreover, the method of drying blood
samples on filter paper is preferable, since it is convenient
for transport purposes, and sterility precautions are un-
necessary.
Time between oral application of sulfamethazine and blood
sample collection
Six individuals were selected for this study. Their acetylation
type was first assessed with the isoniazid test. The concentra-
tion of isozianid was determined 2, 4 and 5 hours after an oral
test dose of 3 mg/kg body weight by the colorimetric method
of Eidus & Harnanansingh (8). The isoniazid concentration in
the serum (mg/1) was plotted against time on semi-logarithmic
paper, and the half life was computed. Individuals with half
lives of 78 ± 14.5 (n = 6; range 60-105) minutes were classi-
fied as rapid inactivators. Slow acetylators had mean half lives
of 228 ± 38.18 minutes.
On other occasions blood was sampled 1 1/2, 2, 4 */2
after oral ingestion of sulfamethazine.
6 hours
Figure 1 illustrates the acetylation rate of sulfametha-
zine in their blood as a function of time. A distinct
separation of the acetylation rate was apparent after
2 hours.
Testing with higher oral doses of sulfamethazine up
to 30 mg/kg body weight, failed to show clear cut
differentiation of phenotypes, when the blood samples
were taken less than 2 hours after sulfamethazine in-
gestion.
Based on the acetylation rate with isoniazid, the rate
of 0.20 could be considered as the demarcation be-
tween the rapid and slow acetylator types, in blood
samples taken 2 hours after a loading test with sulfa-
methazine. From the results of this study we standar-
dized the method as follows:
1. Oral application of sulfamethazine (10 mg/kg'body
weight) after overnight fasting; no food intake before
blood sampling.
2. Two hours later capillary blood is collected by finger
puncture, ear puncture or heel puncture.
3. At least 3 aliquots (each 0.1 rnl) are dropped on filter
paper (Whatman No. 3) and dried at room temperature.
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Fig. 1. a) Time course for the acetylation rate of sulfamethazine
in blood after an oral dose of 10 mg/kg body weight
in slow and rapid acetylators of isoniazid. Each point
represents the mean of 6 normal subjects. Vertical
bars represent the standard deviation.
* denotes p < 0.01 between blood specimen collected
at similar times after the sulfamethazine loading test
from slow and rapid acetylators.
b) the distribution of slow and fast acetylators in two
populations according to the acetylation rate, of
sulfamethazirie in blood at 2 and 4*/2 hours.
4. The subsequent analysis is carried out according to
the method described by Weber ScJirenner (8).
5. The acetylator phenotype is determined according
to the mean result of three determinations, acetylation
rate above 0.20 being the rapid, below 0.20 the slow
type.
Discussion
The use of filter paper methods provides a convenient
technique for safe transportation and storage of the
blood sample. The determination of aeetylator pheno-
types is no longer restricted to the site of testing. After
taking the blood sample and drying it on filter paper,
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the sample can be mailed easily to the laboratory where
the test is performed. The method described above
proved to be very useful and convenient for the pur-
pose of large population genetic studies (12).
As the dosage of sulfamethazine (10 mg/kg body weight)
is low, no side effect is to be expected, except for
people with sulfadrug hypersensitivity. It is recom-
mended that the acetylator phenotype of the patient
should be determined before isoniazid therapy is started.
In the case of the slow type, pyridoxine should be
added in the therapy to prevent the onset of peripheral
neuritis. The increasing number of reports about cases
with isoniazid induced hepatitis or liver necrosis, even in
children (13), also justifies the determination of the
acetylator phenotype before starting the isoniazid
therapy. The studies of Mitchell et al. (14,15) which
revealed the rapid acetylators to be more susceptible to
liver damage, evoke the need of further investigations of
the nature of this polymorphism in man.
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